Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Yoo Website

Min-Hyuk Yoo, Ph.D.

Selected Publications

1)  Yoo MH, Carlson BA, Gladyshev VN, Hatfield DL.
Abrogated thioredoxin system causes increased sensitivity to TNF-a-induced apoptosis via enrichment of p-ERK 1/2 in the nucleus.
PLoS ONE. 8: e71427, 2013.
2)  Patterson AD, Carlson BA, Li F, Bonzo JA, Yoo MH, Krausz KW, Conrad M, Chen C, Gonzalez FJ, Hatfield DL.
Disruption of thioredoxin reductase 1 protects mice from acute acetaminophen-induced hepatotoxicity through enhanced NRF2 activity.
Chem. Res. Toxicol. 26: 1088-96, 2013.
3)  Naranjo-Suarez S, Carlson BA, Tobe R, Yoo MH, Tsuji PA, Gladyshev VN, Hatfield DL.
Regulation of HIF-1a activity by overexpression of thioredoxin is independent of thioredoxin reductase status.
Mol. Cells. 36: 151-7, 2013.
4)  Tsuji PA, Carlson BA, Naranjo-Suarez S, Yoo MH, Xu XM, Fomenko DE, Gladyshev VN, Hatfield DL, Davis CD.
Knockout of the 15 kDa selenoprotein protects against chemically-induced aberrant crypt formation in mice.
PLoS ONE. 7: e50574, 2012.
5)  Tobe R, Yoo MH, Fradejas N, Carlson BA, Calvo S, Gladyshev VN, Hatfield DL.
Thioredoxin reductase 1 deficiency enhances selenite toxicity in cancer cells via a thioredoxin-independent mechanism.
Biochem. J. 445: 423-30, 2012.
6)  Carlson BA, Yoo MH, Tobe R, Mueller C, Naranjo-Suarez S, Hoffmann VJ, Gladyshev VN, Hatfield DL.
Thioredoxin reductase 1 protects against chemically induced hepatocarcinogenesis via control of cellular redox homeostasis.
Carcinogenesis. 33: 1806-13, 2012.
7)  Turanov AA, Xu XM, Carlson BA, Yoo MH, Gladyshev VN, Hatfield DL.
Biosynthesis of selenocysteine, the 21st amino acid in the genetic code, and a novel pathway for cysteine biosynthesis.
Adv Nutr. 2: 122-8, 2011.
8)  Carlson BA, Yoo MH, Conrad M, Gladyshev VN, Hatfield DL, Park JM.
Protein kinase-regulated expression and immune function of thioredoxin reductase 1 in mouse macrophages.
Mol. Immunol. 49: 311-6, 2011.
9)  Yoo MH, Carlson BA, Tsuji P, Irons R, Gladyshev VN, Hatfield DL.
Alteration of thioredoxin reductase 1 levels in elucidating cancer etiology.
Meth. Enzymol. 474: 255-75, 2010.
10)  Cho KJ, Seo JM, Shin Y, Yoo MH, Park CS, Lee SH, Chang YS, Cho SH, Kim JH.
Blockade of airway inflammation and hyperresponsiveness by inhibition of BLT2, a low-affinity leukotriene B4 receptor.
Am. J. Respir. Cell Mol. Biol. 42: 294-303, 2010.
Click Here to View Expanded Bibliography.

This page was last updated on 4/16/2014.